Japan Lifeline Co., Ltd. (TYO:7575)
Japan
· Delayed Price · Currency is JPY 1,454.00
+7.00 (0.48%)
May 30, 2025, 1:44 PM JST
Japan Lifeline Revenue
In the fiscal year ending March 31, 2025, Japan Lifeline had annual revenue of 56.61B JPY with 10.17% growth. Japan Lifeline had revenue of 13.80B in the quarter ending March 31, 2025, with 5.48% growth.
Revenue
56.61B
Revenue Growth
+10.17%
P/S Ratio
1.79
Revenue / Employee
46.55M
Employees
1,216
Market Cap
101.43B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 56.61B | 5.23B | 10.17% |
| Mar 31, 2024 | 51.38B | -366.00M | -0.71% |
| Mar 31, 2023 | 51.75B | 281.00M | 0.55% |
| Mar 31, 2022 | 51.47B | 183.00M | 0.36% |
| Mar 31, 2021 | 51.29B | -475.00M | -0.92% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Daiichi Sankyo Company | 1,886.26B |
| Takeda Pharmaceutical Company | 4,581.55B |
| HOYA Corporation | 869.37B |
| Terumo | 1,036.17B |
| Otsuka Holdings | 2,393.18B |
| Astellas Pharma | 1,912.32B |
| Olympus | 997.33B |